Order Article Reprints

Li X, Lin Y, Niu R, Chen S, Pan J, Zhong Y, Du J, Dong Q, Zhang H, Fang H, et al. Integrated Lipidomics and Network Pharmacology Reveal the AMPK-Mediated Therapeutic Mechanism of 3,3′-Diindolylmethane in Hepatic Lipid Metabolism. Antioxidants. 2025; 14(9):1093. https://doi.org/10.3390/antiox14091093

Li, Xudong, Yunfeng Lin, Ruomei Niu, Siyuan Chen, Jingyun Pan, Yuquan Zhong, Junqiang Du, Qiuxia Dong, Hongfeng Zhang, Heng Fang, and et al. 2025. "Integrated Lipidomics and Network Pharmacology Reveal the AMPK-Mediated Therapeutic Mechanism of 3,3′-Diindolylmethane in Hepatic Lipid Metabolism" Antioxidants 14, no. 9: 1093. https://doi.org/10.3390/antiox14091093

Li, X., Lin, Y., Niu, R., Chen, S., Pan, J., Zhong, Y., Du, J., Dong, Q., Zhang, H., Fang, H., Zhu, H., & Zhu, W. (2025). Integrated Lipidomics and Network Pharmacology Reveal the AMPK-Mediated Therapeutic Mechanism of 3,3′-Diindolylmethane in Hepatic Lipid Metabolism. Antioxidants, 14(9), 1093. https://doi.org/10.3390/antiox14091093